MiRus was granted FDA 510(k) clearance to market the GALILEOâ„¢ Spine Alignment Monitoring System, a non-optical, wireless, real-time measurement system for segmental and global sagittal spine alignment.
GALILEO is reportedly the first FDA-cleared product that can intra-operatively measure sagittal plane alignment without the need for repeated imaging. MiRus plans to incorporate dynamic tracking and feedback into its robotics platform.
MiRus was granted FDA 510(k) clearance to market the GALILEOâ„¢ Spine Alignment Monitoring System, a non-optical, wireless, real-time measurement system for segmental and global sagittal spine alignment.
GALILEO is reportedly the first FDA-cleared product that can intra-operatively measure sagittal plane alignment without the need for...
MiRus was granted FDA 510(k) clearance to market the GALILEOâ„¢ Spine Alignment Monitoring System, a non-optical, wireless, real-time measurement system for segmental and global sagittal spine alignment.
GALILEO is reportedly the first FDA-cleared product that can intra-operatively measure sagittal plane alignment without the need for repeated imaging. MiRus plans to incorporate dynamic tracking and feedback into its robotics platform.
Copy to clipboard 
